• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1例BNT162b2 mRNA新冠疫苗接种后出现的不宁腿综合征病例。

A case of restless legs syndrome after BNT162b2 mRNA COVID-19 vaccination.

作者信息

Ito Hisashi, Kuroki Takahiro, Horiuchi Shigeto, Shinya Yuichi

机构信息

Department of Neurology Shonan Fujisawa Tokushukai Hospital Fujisawa Japan.

Department of Respiratory Medicine Shonan Fujisawa Tokushukai Hospital Fujisawa Japan.

出版信息

Neurol Clin Neurosci. 2022 May;10(3):178-180. doi: 10.1111/ncn3.12594. Epub 2022 Mar 26.

DOI:10.1111/ncn3.12594
PMID:35602174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115277/
Abstract

Restless legs syndrome (RLS) can be secondary to several disorders. We present an 87-year-old woman who developed RLS 2 days after the first injection of BNT162b2 mRNA coronavirus disease 2019 vaccine. The symptoms of RLS tended to improve and eventually resolved with the administration of gabapentin.

摘要

不宁腿综合征（RLS）可能继发于多种疾病。我们报告一名87岁女性，在首次注射BNT162b2 mRNA新型冠状病毒肺炎疫苗后2天出现RLS。使用加巴喷丁后，RLS症状趋于改善并最终缓解。

相似文献

1
A case of restless legs syndrome after BNT162b2 mRNA COVID-19 vaccination.1例BNT162b2 mRNA新冠疫苗接种后出现的不宁腿综合征病例。
Neurol Clin Neurosci. 2022 May;10(3):178-180. doi: 10.1111/ncn3.12594. Epub 2022 Mar 26.
2
Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.加巴喷丁依卡倍特对中重度原发性不宁腿综合征成人国际不宁腿研究组评分量表单项及睡眠后问卷的影响：3项随机试验的汇总分析
Clin Ther. 2016 Jul;38(7):1726-1737.e1. doi: 10.1016/j.clinthera.2016.05.008. Epub 2016 Jun 7.
3
Restless legs syndrome related to hemorrhage of a thoracic spinal cord cavernoma.与胸段脊髓海绵状血管瘤出血相关的不宁腿综合征
J Spinal Cord Med. 2018 Mar;41(2):245-247. doi: 10.1080/10790268.2017.1368963. Epub 2017 Sep 12.
4
Heart rate variability during sleep in children and adolescents with restless sleep disorder: a comparison with restless legs syndrome and normal controls.睡眠不安稳障碍儿童及青少年睡眠期间的心率变异性：与不宁腿综合征及正常对照的比较
J Clin Sleep Med. 2020 Nov 15;16(11):1883-1890. doi: 10.5664/jcsm.8718.
5
Case report of restless anal syndrome as restless legs syndrome variant after COVID-19.病例报告：新冠病毒感染后出现不安腿综合征变异型——不安肛门综合征。
BMC Infect Dis. 2021 Sep 23;21(1):993. doi: 10.1186/s12879-021-06683-7.
6
Diagnostic accuracy of behavioral, activity, ferritin, and clinical indicators of restless legs syndrome.不宁腿综合征的行为、活动、铁蛋白及临床指标的诊断准确性
Sleep. 2015 Mar 1;38(3):371-80. doi: 10.5665/sleep.4492.
7
The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.不宁腿综合征/ Willis-Ekbom 病的长期治疗：循证指南和临床共识最佳实践指南：国际不宁腿综合征研究组的报告。
Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.
8
Epilepsy and restless legs syndrome.癫痫与不宁腿综合征
Epilepsy Behav. 2017 Mar;68:41-44. doi: 10.1016/j.yebeh.2016.12.010. Epub 2017 Jan 19.
9
The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial.透析症状控制-不安腿综合征（DISCO-RLS）试验：一项随机、交叉、安慰剂对照双盲试验方案
Can J Kidney Health Dis. 2020 Nov 26;7:2054358120968959. doi: 10.1177/2054358120968959. eCollection 2020.
10
Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.A型肉毒杆菌毒素成功治疗顽固性不宁腿综合征
J Clin Sleep Med. 2006 Jul 15;2(3):275-8.

引用本文的文献

1
Prevalence of restless legs syndrome during the 2019 coronavirus disease pandemic in South Korea: A nationwide cross-sectional population-based study.韩国2019冠状病毒病大流行期间不宁腿综合征的患病率：一项基于全国横断面人群的研究。
Front Neurol. 2022 Dec 22;13:1101711. doi: 10.3389/fneur.2022.1101711. eCollection 2022.

本文引用的文献

1
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.BNT162b2 mRNA 新冠疫苗在全国范围内使用的安全性。
N Engl J Med. 2021 Sep 16;385(12):1078-1090. doi: 10.1056/NEJMoa2110475. Epub 2021 Aug 25.
2
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.墨西哥 704003 名第一剂 BNT162b2 mRNA COVID-19 疫苗接种者的神经不良反应：一项全国描述性研究。
Clin Immunol. 2021 Aug;229:108786. doi: 10.1016/j.clim.2021.108786. Epub 2021 Jun 18.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Convergence of psychiatric symptoms and restless legs syndrome: A cross-sectional study in an elderly French population.精神症状与不安腿综合征的相关性：一项针对老年法国人群的横断面研究。
J Psychosom Res. 2020 Jan;128:109884. doi: 10.1016/j.jpsychores.2019.109884. Epub 2019 Nov 25.
5
Restless Legs Syndrome: Current Concepts about Disease Pathophysiology.不宁腿综合征：关于疾病病理生理学的当前概念
Tremor Other Hyperkinet Mov (N Y). 2016 Jul 22;6:401. doi: 10.7916/D83J3D2G. eCollection 2016.
6
Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.人乳头瘤病毒疫苗接种后出现的严重躯体形式障碍和自主神经功能障碍综合征：病例系列报道及文献综述
Immunol Res. 2017 Feb;65(1):106-116. doi: 10.1007/s12026-016-8820-z.
7
Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.不宁腿综合征/Willis-Ekbom病诊断标准：更新后的国际不宁腿综合征研究组（IRLSSG）共识标准——病史、基本原理、描述及意义
Sleep Med. 2014 Aug;15(8):860-73. doi: 10.1016/j.sleep.2014.03.025. Epub 2014 May 17.
8
Gabapentin in somatoform and panic disorder.加巴喷丁治疗躯体形式障碍和惊恐障碍。
J Clin Psychopharmacol. 2013 Feb;33(1):140-2. doi: 10.1097/01.jcp.0000426187.42045.a3.
9
The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting.国际不宁腿综合征研究组评定量表及分量表在临床试验环境中的信度、效度和反应度
Sleep Med. 2006 Jun;7(4):340-9. doi: 10.1016/j.sleep.2005.12.011. Epub 2006 May 19.